GAVI

This page shows the latest GAVI news and features for those working in and with pharma, biotech and healthcare.

Gavi says 76 wealthy countries have committed to COVAX vaccine facility

Countries have signed intent to joining COVID-19 vaccine initiative. Gavi vaccines alliance’s chief executive Seth Berkley has revealed that 76 high-income countries have now committed to joining the

Latest news

EU to contribute €400m to WHO’s COVID-19 vaccine facility

The COVAX facility is co-led by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO.
WHO says 172 countries are poised to participate in COVID-19 vaccine initiative

The COVAX initiative is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance and the WHO.
Novartis reveals plans for a zero-profit COVID-19 drugs portfolio

voluntary donation to Gavi’s COVAX Advance Market Commitment (AMC).
Britain closes in on £500m COVID-19 vaccine deal with Sanofi/GSK

The accelerator is jointly led and funded by the Bill &Melinda Gates Foundation, CEPI, FIND, Gavi, The Global Fund, Unitaid, Wellcome, the WHO and the World Bank.
Merck claims first-ever okay for Ebola vaccine, in Europe

continue to produce V920 to supply compassionate-use programmes in the DRC assisted by the WHO, US government and vaccine charity Gavi.

More from news
Approximately 6 fully matching, plus 26 partially matching documents found.

Latest Intelligence

ASEAN: Domestic vaccines manufacturers

GAVI has not limited itself by handing out vaccines to recipient countries, but is driving co-responsibility through co-funding of vaccines. ... One of GAVI's strategic objectives is shaping the vaccine marketplace. By 2011, 5 out of 10 vaccines

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....